1. Home
  2. TGTX vs LEVI Comparison

TGTX vs LEVI Comparison

Compare TGTX & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

N/A

Current Price

$53.27

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Logo Levi Strauss & Co

LEVI

Levi Strauss & Co

BUY

Current Price

$19.82

Market Cap

9.6B

ML Signal

BUY

Company Overview

Basic Information
Metric
TGTX
LEVI
Founded
1993
1853
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
9.6B
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
TGTX
LEVI
Price
$53.27
$19.82
Analyst Decision
Buy
Buy
Analyst Count
8
15
Target Price
★ $69.71
$27.53
AVG Volume (30 Days)
1.5M
★ 2.0M
Earning Date
11-02-2026
10-07-2026
Dividend Yield
N/A
★ 3.12%
EPS Growth
★ 1746.67
178.85
EPS
0.17
★ 0.67
Revenue
$2,785,000.00
★ $6,282,000,000.00
Revenue This Year
$55.81
$7.63
Revenue Next Year
$37.36
$4.85
P/E Ratio
$305.97
★ $30.81
Revenue Growth
N/A
★ N/A
52 Week Low
$26.76
$17.72
52 Week High
$59.30
$25.70

Technical Indicators

Market Signals
Indicator
TGTX
LEVI
Relative Strength Index (RSI) 44.82 42.35
Support Level $51.76 $19.13
Resistance Level $58.26 $20.37
Average True Range (ATR) 2.18 0.49
MACD -0.55 0.15
Stochastic Oscillator 27.90 49.67

Price Performance

Historical Comparison
TGTX
LEVI

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

About LEVI Levi Strauss & Co

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.

Share on Social Networks: